Diabetes Mellitus is Associated with a Higher Relative Risk for Parkinson’s Disease in Women than in Men

The Association Between Type 2 Diabetes Mellitus and Parkinson’s Disease

(2020) Julia L.Y. Cheong et al.   Journal of Parkinsons Disease

Diabetes medications and risk of Parkinson’s disease: a cohort study of patients with diabetes

(2020) Ruth Brauer et al.   BRAIN

Diabetes mellitus is associated with a higher risk for major depressive disorder in women than in men

(2020) Carola Deischinger et al.   BMJ Open Diabetes Research & Care

Association between diabetes and subsequent Parkinson disease

(2018) Eduardo De Pablo-Fernandez et al.   NEUROLOGY

Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

(2018) E. Ray Dorsey et al.   LANCET NEUROLOGY

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial

(2017) Dilan Athauda et al.   LANCET

Glitazone use associated with reduced risk of Parkinson's disease

(2017) Brage Brakedal et al.   MOVEMENT DISORDERS

Hyperuricemia and coronary heart disease mortality: a meta-analysis of prospective cohort studies

(2016) Tian Zuo et al.   BMC Cardiovascular Disorders

The influence of gender and other patient characteristics on health care-seeking behaviour: a QUALICOPC study

(2016) Ashley E. Thompson et al.   BMC Family Practice

Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus

(2016) Alexandra Kautzky-Willer et al.   ENDOCRINE REVIEWS

Neuroendocrine abnormalities in Parkinson's disease

(2016) Eduardo De Pablo-Fernández et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

The epidemiology of Parkinson's disease: risk factors and prevention

(2016) Alberto Ascherio et al.   LANCET NEUROLOGY

The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis

(2016) Lauren Hirsch et al.   NEUROEPIDEMIOLOGY

Insulin resistance and Parkinson’s disease: A new target for disease modification?

(2016) D. Athauda et al.   PROGRESS IN NEUROBIOLOGY

Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial

(2015)   LANCET NEUROLOGY

Quantification of Diabetes Comorbidity Risks across Life Using Nation-Wide Big Claims Data

(2015) Peter Klimek et al.   PLoS Computational Biology

Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events

(2014) Sanne A. E. Peters et al.   DIABETOLOGIA

Alcohol intake and risk of Parkinson's disease: A meta-analysis of observational studies

(2014) Dongfeng Zhang et al.   MOVEMENT DISORDERS

Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study

(2013) H. Ding et al.   NEUROLOGY

Integrative Network Analysis Unveils Convergent Molecular Pathways in Parkinson's Disease and Diabetes

(2013) Jose A. Santiago et al.   PLoS One

Shared dysregulated pathways lead to Parkinson's disease and diabetes

(2013) Jose A. Santiago et al.   TRENDS IN MOLECULAR MEDICINE

Meta-analysis of early nonmotor features and risk factors for Parkinson disease

(2012) Alastair J. Noyce et al.   ANNALS OF NEUROLOGY

Parkinson's disease, insulin resistance and novel agents of neuroprotection

(2012) Iciar Aviles-Olmos et al.   BRAIN

Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort

(2012) Mark L. Wahlqvist et al.   PARKINSONISM & RELATED DISORDERS

Diabetes and Risk of Parkinson's Disease

(2011) Q. Xu et al.   DIABETES CARE

Serum Vitamin D and the Risk of Parkinson Disease

(2010) Paul Knekt et al.   ARCHIVES OF NEUROLOGY

Smoking duration, intensity, and risk of Parkinson disease

(2010) H. Chen et al.   NEUROLOGY

Occurrence of depression and anxiety prior to Parkinson’s disease

(2010) E.L. Jacob et al.   PARKINSONISM & RELATED DISORDERS